Nazobic Nasal Spray, containing Fluticasone Furoate (27.5mcg per actuation), is an intranasal corticosteroid indicated for the management of seasonal and perennial allergic rhinitis in adults and pediatric patients aged 4 years and older. It effectively reduces nasal inflammation and alleviates symptoms such as sneezing, rhinorrhea, nasal pruritus, and nasal congestion. The metered dose aerosol spray is designed for easy administration, delivering a consistent dose per actuation. Nazobic should be used with caution in patients with a history of glaucoma, cataracts, or ocular herpes simplex. Common adverse effects include nasal irritation, headache, and pharyngitis. Always consult with a healthcare provider before starting or adjusting treatment.